atropine has been researched along with am-356 in 1 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (am-356) | Trials (am-356) | Recent Studies (post-2010) (am-356) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 216 | 0 | 42 |
Protein | Taxonomy | atropine (IC50) | am-356 (IC50) |
---|---|---|---|
Potassium channel subfamily K member 3 | Homo sapiens (human) | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adinolfi, B; Breschi, MC; Calderone, V; Martinotti, E; Nieri, P; Testai, L | 1 |
1 other study(ies) available for atropine and am-356
Article | Year |
---|---|
R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.
Topics: Acetylcholine; Animals; Arachidonic Acids; Atropine; Benzoxazines; Cannabinoid Receptor Modulators; Capsaicin; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Indoles; Male; Morpholines; Muscle Contraction; Muscle, Smooth; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Trachea | 2003 |